Cargando…

YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy

BACKGROUND: Pathological cardiac hypertrophy is a major contributor of heart failure (HF), which seriously threatens human’s health world widely. Deregulation of m6A RNA methylation, and m6A methyltransferases and de-methyltransferases have been demonstrated to act essential roles in cardiac hypertr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hongfei, Wang, Zhen, Chen, Miao, Zhao, Wenting, Tao, Tingting, Ma, Liang, Ni, Yiming, Li, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281596/ https://www.ncbi.nlm.nih.gov/pubmed/34266473 http://dx.doi.org/10.1186/s13578-021-00649-7

Ejemplares similares

A NFAT decoy approach to inhibit cardiac hypertrophy
por: Heineke, Joerg
Publicado: (2021)

GSTM2 alleviates heart failure by inhibiting DNA damage in cardiomyocytes
por: Xu, Hongfei, et al.
Publicado: (2023)

YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation
por: Li, Jiong, et al.
Publicado: (2021)

Pressure Overload-induced Cardiac Hypertrophy Varies According to Different Ligation Needle Sizes and Body Weights in Mice
por: Jia, Zhen, et al.
Publicado: (2018)

AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
por: Remes, Anca, et al.
Publicado: (2021)

ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1
por: Han, Zhenbo, et al.
Publicado: (2021)

A Novel HRAS Mutation Independently Contributes to Left Ventricular Hypertrophy in a Family with a Known MYH7 Mutation
por: Sana, Maria Elena, et al.
Publicado: (2016)

The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m(6)A RNA methylation reading protein Ythdf2
por: Yang, Yiqing, et al.
Publicado: (2022)

The contribution of mutations in MYH7 to the onset of cardiomyopathy
por: Bollen, I. A. E., et al.
Publicado: (2017)

Genetic Association of Beta-Myosin Heavy-Chain Gene (MYH7) with Cardiac Dysfunction
por: Yousaf, Memoona, et al.
Publicado: (2022)

Ythdf2-mediated m(6)A mRNA clearance modulates neural development in mice
por: Li, Miaomiao, et al.
Publicado: (2018)

The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis
por: Sun, Ruimin, et al.
Publicado: (2022)

METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer
por: Zhan, Lei, et al.
Publicado: (2023)

Anti-tumor immunity controlled through mRNA m(6)A and YTHDF1 in dendritic cells
por: Han, Dali, et al.
Publicado: (2019)

YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation
por: Huang, Chen‐Song, et al.
Publicado: (2022)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

Linc‐MYH configures INO80 to regulate muscle stem cell numbers and skeletal muscle hypertrophy
por: Schutt, Christian, et al.
Publicado: (2020)

Inhibition of mTOR or MAPK ameliorates vmhcl/myh7 cardiomyopathy in zebrafish
por: Bu, Haisong, et al.
Publicado: (2021)

Allele-Selective Knockdown of MYH7 Using Antisense Oligonucleotides
por: Anderson, Brian R., et al.
Publicado: (2020)

A Family with Myh7 Mutation and Different Forms of Cardiomyopathies
por: Catrina, Bianca Iulia, et al.
Publicado: (2023)

Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3
por: Zhang, Meiqi, et al.
Publicado: (2022)

YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation
por: Ye, Jing, et al.
Publicado: (2020)

ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9‐induced deubiquitination of β‐catenin to block gastric cancer metastasis
por: Liu, Jiahao, et al.
Publicado: (2022)

Autoantibody:Autoantigen Competitor Decoys: Application to Cardiac Phenotypes
por: Cardozo, Timothy, et al.
Publicado: (2022)

YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m(6)A/mRNA pathway
por: Huang, Tao, et al.
Publicado: (2020)

The mRNA m(6)A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function
por: Mapperley, Christopher, et al.
Publicado: (2020)

Autophagy induction promoted by m(6)A reader YTHDF3 through translation upregulation of FOXO3 mRNA
por: Hao, WeiChao, et al.
Publicado: (2022)

DecoyFinder, a tool for finding decoy molecules
por: Adrià, Cereto Massagué, et al.
Publicado: (2012)

MYH9 nephropathy
por: Oh, Taehoon, et al.
Publicado: (2015)

Adeno-associated virus-mediated delivery of anti-miR-199a tough decoys attenuates cardiac hypertrophy by targeting PGC-1alpha
por: Yan, Hualin, et al.
Publicado: (2020)

Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy
por: Song, Chao, et al.
Publicado: (2016)

Nonmuscle myosin 2 proteins encoded by Myh9, Myh10, and Myh14 are uniquely distributed in the tubular segments of murine kidney
por: Otterpohl, Karla L., et al.
Publicado: (2017)

YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
por: Li, Jiangfeng, et al.
Publicado: (2020)

Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting the JAK2/STAT3 signalling pathway
por: Fan, Cai‐lian, et al.
Publicado: (2022)

Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles
por: Rossi, Alberto C, et al.
Publicado: (2010)

Gastrodin Inhibits Store-Operated Ca(2+) Entry and Alleviates Cardiac Hypertrophy
por: Zheng, Changbo, et al.
Publicado: (2017)

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
por: Zhang, Xin, et al.
Publicado: (2020)

FBW7 suppresses ovarian cancer development by targeting the N(6)-methyladenosine binding protein YTHDF2
por: Xu, Fei, et al.
Publicado: (2021)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

The N(6)-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy
por: Dorn, Lisa E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_isk10iub7apqsd8ibrflu70dn6